Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 1.723 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 1.723 | 1 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.2301 | 0.0797 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.2301 | 0.0797 | 0.3974 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.2301 | 0.0797 | 1 |
Onchocerca volvulus | 0.314 | 0.1314 | 0.5 | |
Entamoeba histolytica | carbonic anhydrase, putative | 0.4263 | 0.2006 | 0.5 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.2301 | 0.0797 | 1 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.2301 | 0.0797 | 1 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.4263 | 0.2006 | 1 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.3627 | 0.1615 | 0.1263 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.2301 | 0.0797 | 0.5 |
Schistosoma mansoni | carbonic anhydrase | 0.4263 | 0.2006 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.2301 | 0.0797 | 1 |
Echinococcus multilocularis | carbonic anhydrase II | 0.2301 | 0.0797 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.2301 | 0.0797 | 0.3974 |
Leishmania major | carbonic anhydrase family protein, putative | 0.4263 | 0.2006 | 1 |
Onchocerca volvulus | Putative sulfate transporter | 0.314 | 0.1314 | 0.5 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.59 | 0.3016 | 0.3016 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.2301 | 0.0797 | 0.5 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 1.4956 | 0.8599 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.2301 | 0.0797 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.